Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers

Por Farr, Stephen J, Robinson, Cynthia Y, Rubino, Christopher M
Publicado no Clin Pharmacol (2015)

Determination of Appropriate Weight-Based Cutoffs for Empiric Cefazolin Dosing Using Data from a Phase 1 Pharmacokinetics and Safety Study of Cefazolin Administered for Surgical Pr...

Por Schmitz, Michael L., Blumer, Jeffrey L., Cetnarowski, Wes, Rubino, Christopher M.
Publicado no Antimicrob Agents Chemother (2015)

Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae: Report from the Antimicrobial Res...

Por Jones, Ronald N., Rubino, Christopher M., Bhavnani, Sujata M., Ambrose, Paul G.
Publicado em 2003

A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers

Por Pan, Lin, Belloni, Paula, Ding, Han Ting, Wang, Jianshuang, Rubino, Christopher M., Putnam, Wendy S.
Publicado no Adv Ther (2017)

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

Por Bhavnani, Sujata M., Ambrose, Paul G., Hammel, Jeffrey P., Rubino, Christopher M., Drusano, George L.
Publicado no Antimicrob Agents Chemother (2016)

Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself

Por Ambrose, Paul G., VanScoy, Brian, Conde, Haley, McCauley, Jennifer, Rubino, Christopher M., Bhavnani, Sujata M.
Publicado no Antimicrob Agents Chemother (2016)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Por Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
Publicado em 2009

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

Por Rubino, Christopher M., Forrest, Alan, Bhavnani, Sujata M., Dukart, Gary, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G.
Publicado em 2010

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis to Support VL-2397 Dose Selection for a Phase 2 Trial in Patients with Invasive Aspergillosis

Por Rubino, Christopher M, Smith, Larry R, Mammen, Mammen P, Hopkins, Andrew M, Lakota, Elizabeth A, Sullivan, Sean M
Publicado no Open Forum Infect Dis (2017)

Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics

Por Ambrose, Paul G., Hammel, Jeffrey P., Bhavnani, Sujata M., Rubino, Christopher M., Ellis-Grosse, Evelyn J., Drusano, George L.
Publicado em 2012

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Por Rubino, Christopher M., Bhavnani, Sujata M., Forrest, Alan, Dukart, Gary, Dartois, Nathalie, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G.
Publicado em 2012

At the Crossroads of Stewardship and Technology: Impact of Pharmacokinetic-Pharmacodynamic (PK-PD) Integrated Electronic Decision Support Software (EDSS) on the Treatment of Patien...

Por Bader, Justin C, Bulik, Catharine C, Bhavnani, Sujata M, Rubino, Christopher M, Sweeney, Kim L, Ambrose, Paul G, Owens, Robert C
Publicado no Open Forum Infect Dis (2017)

Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline

Por Bhavnani, Sujata M., Rubino, Christopher M., Hammel, Jeffrey P., Forrest, Alan, Dartois, Nathalie, Cooper, C. Angel, Korth-Bradley, Joan, Ambrose, Paul G.
Publicado em 2012

Population Pharmacokinetic Model for Gatifloxacin in Pediatric Patients

Por Rubino, Christopher M., Capparelli, Edmund V., Bradley, John S., Blumer, Jeffrey L., Kearns, Gregory L., Reed, Michael, Jacobs, Richard F., Cirincione, Brenda, Grasela, Dennis M.
Publicado em 2007

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptoc...

Por Van Wart, Scott A., Ambrose, Paul G., Rubino, Christopher M., Khariton, Tatiana, Riccobene, Todd A., Friedland, H. David, Critchley, Ian A., Bhavnani, Sujata M.
Publicado em 2014

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory

Por Belley, Adam, Robson, Richard, Francis, John L., Adcock, Dorothy M., Tiefenbacher, Stefan, Rubino, Christopher M., Moeck, Greg, Sylvester, David, Dudley, Michael N., Loutit, Jeffery
Publicado no Antimicrob Agents Chemother (2017)

Getting it Right the First Time: Relating Pharmacokinetic-Pharmacodynamic Target Attainment and Patient Outcomes

Por Bulik, Catharine C, Bader, Justin C, Lakota, Elizabeth A, Bhavnani, Sujata M, Rubino, Christopher M, Sweeney, Kim L, Ambrose, Paul G, Owens, Robert C
Publicado no Open Forum Infect Dis (2017)

Evaluation of Tigecycline Penetration into Colon Wall Tissue and Epithelial Lining Fluid Using a Population Pharmacokinetic Model and Monte Carlo Simulation

Por Rubino, Christopher M., Ma, Lei, Bhavnani, Sujata M., Korth-Bradley, Joan, Speth, John, Ellis-Grosse, Evelyn, Rodvold, Keith R., Ambrose, Paul G., Drusano, George L.
Publicado em 2007

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model

Por VanScoy, Brian D., Tenero, David, Turner, Simon, Livermore, David M., McCauley, Jennifer, Conde, Haley, Bhavnani, Sujata M., Rubino, Christopher M., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2017)

Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters

Por Lakota, Elizabeth A., Bader, Justin C., Ong, Voon, Bartizal, Ken, Miesel, Lynn, Andes, David R., Bhavnani, Sujata M., Rubino, Christopher M., Ambrose, Paul G., Lepak, Alexander J.
Publicado no Antimicrob Agents Chemother (2017)